Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sickle Cell Disease in Brazil: Current Management.
da Silva Araújo A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, Menosi Gualandro SF, Olalla Saad ST, Cançado RD. da Silva Araújo A, et al. Among authors: menosi gualandro sf. Hemoglobin. 2024 Jul;48(4):218-230. doi: 10.1080/03630269.2024.2344790. Epub 2024 Apr 25. Hemoglobin. 2024. PMID: 38663998 Review.
Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
Araújo ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, Menosi Gualandro SF, Olalla Saad ST, Cancado RD. Araújo ADS, et al. Among authors: menosi gualandro sf. Hemoglobin. 2023 Nov;47(2):71-79. doi: 10.1080/03630269.2023.2211771. Epub 2023 Jun 12. Hemoglobin. 2023. PMID: 37309063 Review.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Kulasekararaj AG, Griffin M, Langemeijer S, Usuki K, Kulagin A, Ogawa M, Yu J, Mujeebuddin A, Nishimura JI, Lee JW, Peffault de Latour R; 301/302 Study Group. Kulasekararaj AG, et al. Eur J Haematol. 2022 Sep;109(3):205-214. doi: 10.1111/ejh.13783. Epub 2022 Jun 16. Eur J Haematol. 2022. PMID: 35502600 Free PMC article. Clinical Trial.
-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
Oliveira VB, Dezan MR, Gomes FCA, Menosi Gualandro SF, Krieger JE, Pereira AC, Marsiglia JD, Levi JE, Rocha V, Mendrone-Junior A, Sabino EC, Dinardo CL. Oliveira VB, et al. Among authors: menosi gualandro sf. Int J Immunogenet. 2017 Oct;44(5):219-224. doi: 10.1111/iji.12334. Epub 2017 Aug 17. Int J Immunogenet. 2017. PMID: 28815969